Julia Moore's perspective is shaped by having worked in public-markets research, venture investing, and hands-on operating roles, which lets her judge not just whether the science is promising but what it actually takes to reach a successful exit, and she focuses less on great science alone and more on cutting the time, cost, and risk of development while pushing founders to get early validation from corporate partners, public investors, and grants rather than staying inside a venture bubble. She also pays close attention to hidden practical know-how, like hard-to-transfer lab skills, as a hidden source of wasted time and money in biotech, and she argues that AI's real advantage in biology comes from proprietary data and learning loops rather than just using existing AI models.